A Phase Ib study of NeoVax plus Montanide in combination with Nivolumab and locally administered Ipilimumab in patients with melanoma
NOT ENROLLING
Trial ID:
NCT03929029 Protocol # :
18-279
Phase
I
Disease Sites
Melanoma, Skin
Principal Investigator
Ott, Patrick
Site Research Nurses
Baylies, Rosemarie
Carey, Margaret, M.
Connors, Lauren
Gillen Mckay, Christine, A.
Gormley, Jill, Kathleen
Kelliher, Elizabeth
Livengood, Amanda
Rang, Bethany
Rowan, Jennifer, M.
Trial Description
Call 877-DF-TRIAL (877-338-7425) to learn more about this clinical trial, protocol #18-279
18-279